Tosi Davide, Palleschi Alessandro, Musso Valeria, Mazzucco Alessandra, Cattaneo Margherita, Carrinola Rosaria, Damarco Francesco, Mendogni Paolo
Thoracic Surgery and Lung Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
J Thorac Dis. 2020 Jun;12(6):3411-3417. doi: 10.21037/jtd.2020.01.26.
Traditionally, pulmonary lobectomy has always been considered as the gold standard for the treatment of early stage non-small cell lung cancer (NSCLC); limited resections have been proposed in case of "compromised" patients, with relevant comorbidities. In the last years, the interest in anatomical segmentectomies among surgeons has been progressively growing, even for patients fit for lobectomy, in selected cases. In this article we debate the current trends in the treatment of early stage NSCLC around Europe.
传统上，肺叶切除术一直被视为早期非小细胞肺癌（NSCLC）治疗的金标准；对于有相关合并症的“身体状况不佳”患者，有人提出进行有限切除。在过去几年中，即使是适合肺叶切除术的患者，在某些特定情况下，外科医生对解剖性肺段切除术的兴趣也在逐渐增加。在本文中，我们讨论了欧洲早期NSCLC治疗的当前趋势。
